Glycopyrrolate Injection
Product Images NDC 0404-9867

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0404-9867). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

The chemical structure information provided is for a compound named CisHuBrNO, having a molecular weight of 39833 g/mol. This compound contains Br, CH, and N atoms. OH groups are also present in the structure.*

FDA Label Image

Image1.jpg (Image1)

This appears to be a table with two groups labelled as "cL" and their respective rates of (L/kg/hr) and (Hg/Lehr) AUC values. The first group's rate is 0.54 and AUC value is 8.64 Hg/Lehr, while the second group's rate is 0.14 and AUC value is 1.49 Hg/Lehr. There also seems to be an additional percentage value of 6.64 and a number 233. However, without additional context, it is difficult to determine the significance of these numbers.*

FDA Label Image

Label1.jpg (Label1)

Glycopyrrolate is a medication that is not suitable for use in newborns. It can be administered through intramuscular or intravenous routes. The product should be stored between 20 and 25°C and out of the children's reach. It contains benzyl alcohol. The text also lists a lot number, item number, and manufacturer's instructions on usage, but they are not legible due to errors. The product is packaged by Henry Schein Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.